BUY
|
Original-Research: NFON AG - from NuWays AG
Classification of NuWays AG to NFON AG
More to come after solid start into the year; chg. Q1’25 sales increased by 4.0% yoy to € 22.1m (eNuW: € 22.4m), of which € 20.8m were of recurring nature, implying a 94.0% recurring revenue ratio. Main driver of the increasing top-line was botario, which was acquired at the end of Q3’24. With € 0.8m sales in Q1 (+52% yoy), botario explained about 90% of Q1 growth, thus implying organic growth of only 0.4%. The reasons for the flattish organic sales development are as follows. (1) As planned, non-recurring (especially hardware) sales further decreased by 0.9% yoy to € 1.3m. (2) The migration of DTS clients to the NFON platform was binding resources at partners, that could not be used for seat growth. The good thing is, that 40% of clients were already migrated in the first quarter and the remaining 60% are expected to be so until YE. Improving ARPU. For the first time since Covid, NFON achieved a Q1 blended ARPU of above € 10 with € 10.02, clearly reflecting the increasing focus on premium solutions, which is seen to drive ARPU and thus margins further going forward. Despite an improved gross margin (+1.9pp to 86%), adj. EBITDA slightly decreased yoy to € 2.6m (Q1:24: € 2.8m), implying a margin of 11.8%. Main reason for the decline were planned investments in personnel and other OpEx related to AI initiatives. Nevertheless, NFON was able to improve FCF significantly from € 0.2m in Q1’24 to € 1.1m on the back of favorable WC swings. Guidance confirmed. After a solid start to the year, management confirmed the FY25 guidance of 8-10% sales growth and € 13.5-15.5m adj. EBITDA. Reaching the mid-point would require 10.6% sales growth on average in the coming quarters as well as a 16.3% adj. EBITDA margin. Despite the, top-line wise, slow start this looks absolutely achievable in our view, as (1) the DTS migration is proceeding well, which should already become visible in Q2, (2) lead-times in the core business are already normalizing (3) strategic price increases starting in May as well as new AI products (e.g. voicemail transcription, NIA) gaining traction. Moreover, the tune of quarterly investments into AI and personnel should normalize, thus benefitting margins. We keep our conviction in the case, which has the potential to become one of the key-players in AI supported communication services, backed by a strong core business. We hence reiterate BUY with a € 12.30 PT and keep the stock in our NuWays Alpha List. You can download the research here: http://www.more-ir.de/d/32708.pdf For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2144074 23.05.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.